Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 7722 > 

7722-64-7

Products Categories

Basic Information
CAS No.: 7722-64-7
Name: Potassium permanganate(VII)
Molecular Structure:
Molecular Structure of 7722-64-7 (Potassium permanganate(VII))
Formula: KMnO4
Molecular Weight: 158.034
Synonyms: Permanganicacid (HMnO4), potassium salt (8CI,9CI);Allways Fresh;C.I. 77755;Cairox;Chameleon mineral;Condy's crystals;GS-KP;HY 5;Permanganic acid potassiumsalt;Pure Light E 2;Tarco 4338C;Turco 4338C;
EINECS: 231-760-3
Density: 1.01 g/mL at 25 °C
Melting Point: 240 °C
Solubility: water: 6.4 g/100 mL (20 °C)
Appearance: purplish colored crystalline solid
Hazard Symbols: OxidizingO,HarmfulXn,DangerousN,IrritantXi
Risk Codes: 8-51/53-50/53-22-52/53-36/38
Safety: 60-61-36-26
Transport Information: UN 3082 9/PG 3
PSA: 74.27000
LogP: -0.47520
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

History

In 1659 a German chemist, J.R. Glauber, fused a mixture of the mineral pyrolusite and potassium carbonate to obtain a material that, when dissolved in water, gave a green solution (potassium manganate) which slowly shifted to violet potassium permanganate and then finally red. This report represents the first description of the production of potassium permanganate. Just under two hundred years later London chemist Henry Bollmann Condy had an interest in disinfectants, and marketed several products including ozonised water. He found that fusing pyrolusite with NaOH and dissolving it in water produced a solution with disinfectant properties. He patented this solution, and marketed it as Condy's Fluid. Although effective, the solution was not very stable. This was overcome by using KOH rather than NaOH. This was more stable, and had the advantage of easy conversion to the equally effective potassium permanganate crystals. This crystalline material was known as Condy’s crystals or Condy’s powder. Potassium permanganate was comparatively easy to manufacture so Condy was subsequently forced to spend considerable time in litigation in order to stop competitors from marketing products similar to Condy's Fluid or Condy's Crystals.

Specification

Potassium permanganate , its cas register number is 7722-64-7. It also can be called Algae-K ; Argucide ; Cairox ; Condy's crystals ; Diversey Diversol CX with Arodyne ; Icc 237 Disinfectant, Sanitizer, Destainer, and Deodorizer ; Insta-perm ; Kaliumpermanganat ; Permanganate de potassium ; Permanganate of potash .It is a purplish colored crystalline solid. Noncombustible but accelerates the burning of combustible material. If the combustible material is finely divided the mixture may be explosive. It contact with liquid combustible materials may result in spontaneous ignition. Contact with sulfuric acid may cause fire or explosion. Soluble in water.

Physical properties about Potassium permanganate are: (1)H-Bond Donor: 0; (2)H-Bond Acceptor: 4; (3)EINECS: 231-760-3; (4)Melting Point: 240 °C; (5)Density: 1.01 g/mL at 25 °C; (6)Storage temp.: Store at RT.; (7)Solubility: H2O: 0.1 M at 20 °C, complete, violet; (8)Form: solution (volumetric); (9)Water Solubility: 6.4 g/100 mL (20 °C);

Preparation of Potassium permanganate: Potassium permanganate is manufactured on a large scale from manganese dioxide. The mineral pyrolusite is fused with potassium hydroxide and heated in air or with potassium nitrate. This process gives potassium manganate, which upon electrolytic oxidation in alkaline solution gives potassium permanganate.
2 MnO2 + 2 KOH + 3/2 O2 → 2 KMnO4 + H2O
2MnO42- + Cl2 → 2MnO4-+ 2Cl-

Uses of Potassium permanganate: Almost all applications of Potassium permanganate (CAS NO.7722-64-7) exploit its oxidizing properties.As a strong oxidant that does not generate toxic byproducts, it has many niche uses.Following is the uses: Disinfectant and water treatment,As an oxidant, potassium permanganate can act as a disinfectant; Biomedical uses,Related to the use of KMnO4 for water treatment, this salt is often employed as a specialized disinfectant for treating human and animal ailments; Organic synthesis,Aside from its use in water treatment, the other major application of KMnO4 is as a reagent for the synthesis of organic compounds; Analytical chemistry, Potassium permanganate can be used to quantitatively determine the total oxidisable organic material in an aqueous sample; Organic chemistry, Dilute solutions of KMnO4 convert alkenes into diols (glycols).

When you are using this chemical, please be cautious about it as the following:
1. This material and/or its container must be disposed of as hazardous waste;
2. Avoid release to the environment. Refer to special instructions safety data sheet;
3. Wear suitable protective clothing;
4. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice;

You can still convert the following datas into molecular structure:
(1)InChI=1S/K.Mn.4O/q+1;;;;;-1;
(2)InChIKey=VZJVWSHVAAUDKD-UHFFFAOYSA-N;
(3)Smiles[Mn](=O)(=O)(=O)[O-].[K+];

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo oral 400mg/kg (400mg/kg)   Yakkyoku. Pharmacy. Vol. 31, Pg. 855, 1980.
guinea pig LD50 oral 1151mg/kg (1151mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 36(9), Pg. 15, 1971.
human LDLo oral 143mg/kg (143mg/kg) GASTROINTESTINAL: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 493, 1969.
mouse LD50 oral 2157mg/kg (2157mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 36(9), Pg. 15, 1971.
rabbit LDLo intravenous 70mg/kg (70mg/kg)   Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975.
 
rabbit LDLo oral 600mg/kg (600mg/kg)   Yakkyoku. Pharmacy. Vol. 31, Pg. 855, 1980.
rat LD50 oral 1090mg/kg (1090mg/kg)   American Industrial Hygiene Association Journal. Vol. 30, Pg. 470, 1969.
 
women LDLo oral 100mg/kg (100mg/kg) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"

LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE"
Human & Experimental Toxicology. Vol. 15, Pg. 259, 1996.
 
women TDLo oral 2400ug/kg/D (2.4mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING Archives Internationales de Pharmacodynamie et de Therapie. Vol. 44, Pg. 446, 1933.